Senators voice interest in Medicare Part D, Part B reforms

Modern Healthcare: The Senate Finance Committee on Tuesday signaled interest in bolstering key points in the Trump administration's drug-pricing blueprint, including potential structural reforms for Medicare Part B and Part D.

Senators from both sides of the aisle waded into a proposal highly unpopular with physicians and hospitals, aimed at removing the incentive for providers who administer drugs under Medicare Part B to prescribe the most expensive option.

Read article